$CLCS
Cell Source, Inc. Stock $clcs

$clcs Overview Financials Valuation SEC Filings Company Website

2022 Q2 Form 10-Q Financial Statement

#000149315222034255 Filed on December 02, 2022

Income Statement

Concept	2022 Q2	2021 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$464.4K	$627.6K
YoY Change	-26.0%	-9.5%
% of Gross Profit
Research & Development	$555.0K	$367.6K
YoY Change	51.0%	75.08%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.034M	$995.1K
YoY Change	3.9%	10.16%
Operating Profit	-$1.034M	-$995.1K
YoY Change	3.9%
Interest Expense	$63.31K	-$318.0K
YoY Change	-119.91%	144.42%
% of Operating Profit
Other Income/Expense, Net	-$251.7K	-$318.0K
YoY Change	-20.85%
Pretax Income	-$1.286M	-$1.313M
YoY Change	-2.1%	12.74%
Income Tax
% Of Pretax Income
Net Earnings	-$1.286M	-$1.313M
YoY Change	-2.1%	12.74%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.04	-$0.05
Diluted Earnings Per Share	-$37.33K	-$40.20K
COMMON SHARES
Basic Shares Outstanding	34.44M shares	32.66M shares
Diluted Shares Outstanding	34.44M shares

Balance Sheet

Concept	2022 Q2	2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.600K	$81.71K
YoY Change	-96.82%	7261.26%
Cash & Equivalents	$2.597K	$85.21K
Short-Term Investments
Other Short-Term Assets	$16.13K	$223.3K
YoY Change	-92.78%	175.1%
Inventory
Prepaid Expenses	$25.91K
Receivables
Other Receivables
Total Short-Term Assets	$44.64K	$305.0K
YoY Change	-85.37%	270.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$3.500K
YoY Change
Total Long-Term Assets	$0.00	$3.500K
YoY Change	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$44.64K	$305.0K
Total Long-Term Assets	$0.00	$3.500K
Total Assets	$44.64K	$308.5K
YoY Change	-85.53%	274.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$382.0K	$340.0K
YoY Change	12.36%	-23.74%
Accrued Expenses	$1.501M	$2.826M
YoY Change	-46.89%	17.71%
Deferred Revenue
YoY Change
Short-Term Debt	$750.5K	$813.4K
YoY Change	-7.73%	-26.92%
Long-Term Debt Due	$806.7K	$5.835M
YoY Change	-86.18%	178.53%
Total Short-Term Liabilities	$10.81M	$10.34M
YoY Change	4.6%	56.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.81M	$10.34M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$10.81M	$10.34M
YoY Change	4.6%	56.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$33.76M	-$28.54M
YoY Change	18.26%
Common Stock	$35.24K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.77M	-$10.03M
YoY Change
Total Liabilities & Shareholders Equity	$44.64K	$308.5K
YoY Change	-85.53%	274.94%

Cashflow Statement

Concept	2022 Q2	2021 Q2
OPERATING ACTIVITIES
Net Income	-$1.286M	-$1.313M
YoY Change	-2.1%	12.74%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$300.6K	-$1.143M
YoY Change	-73.71%	113.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	171.2K	1.125M
YoY Change	-84.79%	116.43%
NET CHANGE
Cash From Operating Activities	-300.6K	-1.143M
Cash From Investing Activities
Cash From Financing Activities	171.2K	1.125M
Net Change In Cash	-129.4K	-17.89K
YoY Change	623.25%	16.09%
FREE CASH FLOW
Cash From Operating Activities	-$300.6K	-$1.143M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001569340
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	CLCS	Gain On Forgiveness Of Accrued Interest GainOnForgivenessOfAccruedInterest		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense		usd
	CLCS	Common Stock Based Compensation CommonStockBasedCompensation		usd
	CLCS	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2022Q2	us-gaap	Restricted Cash RestrictedCash		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	CLCS	Issuance Of Common Stock Pursuant To Cashless Warrant Exercise IssuanceOfCommonStockPursuantToCashlessWarrantExercise		usd
	CLCS	Accrued Interest Converted Into Notes Payable AccruedInterestConvertedIntoNotesPayable		usd
	CLCS	Accrual Of Warrant Obligations In Connection With Issuance Of Notes Payable AccrualOfWarrantObligationsInConnectionWithIssuanceOfNotesPayable		usd
	CLCS	Issuance Of Warrants In Satisfaction Of Accrued Interest IssuanceOfWarrantsInSatisfactionOfAccruedInterest		usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55413
	dei	Entity Registrant Name EntityRegistrantName	Cell Source, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	32-0379665
	dei	Entity Address Address Line1 EntityAddressAddressLine1	57 West 57th Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 400
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
	dei	City Area Code CityAreaCode	(646)
	dei	Local Phone Number LocalPhoneNumber	416-7896
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35252389	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2597	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93095	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	25911	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	203750	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	16132	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	16922	usd
CY2022Q2	us-gaap	Assets Assets	44640	usd
CY2021Q4	us-gaap	Assets Assets	313767	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	382009	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	223041	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1500937	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1097021	usd
CY2022Q2	CLCS	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	72000	usd
CY2021Q4	CLCS	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	72000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	759829	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	725308	usd
CY2022Q2	CLCS	Accrued Interest Related Parties Current AccruedInterestRelatedPartiesCurrent	814192	usd
CY2021Q4	CLCS	Accrued Interest Related Parties Current AccruedInterestRelatedPartiesCurrent	456917	usd
CY2022Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	798240	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	766102	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	750499	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	759912	usd
CY2022Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	150000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	150000	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	656729	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1834446	usd
CY2022Q2	CLCS	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	4652078	usd
CY2021Q4	CLCS	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	3725000	usd
CY2022Q2	CLCS	Advances Payable Current AdvancesPayableCurrent	135000	usd
CY2021Q4	CLCS	Advances Payable Current AdvancesPayableCurrent	135000	usd
CY2022Q2	CLCS	Advances Payable Related Party Current AdvancesPayableRelatedPartyCurrent	100000	usd
CY2021Q4	CLCS	Advances Payable Related Party Current AdvancesPayableRelatedPartyCurrent	100000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	27926	usd
CY2022Q2	us-gaap	Dividends Payable Current DividendsPayableCurrent	39686	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	67229	usd
CY2022Q2	us-gaap	Liabilities Liabilities	10811199	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10139902	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35239669	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35239669	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34360546	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34360546	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	35240	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	34361	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22952986	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21316318	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33756597	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31178428	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-10766559	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9826135	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44640	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	313767	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	555010	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	355051	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1019515	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	590815	usd
CY2022Q2	CLCS	Research And Development Related Party ResearchAndDevelopmentRelatedParty	14500	usd
CY2021Q2	CLCS	Research And Development Related Party ResearchAndDevelopmentRelatedParty	12500	usd
	CLCS	Research And Development Related Party ResearchAndDevelopmentRelatedParty	29000	usd
	CLCS	Research And Development Related Party ResearchAndDevelopmentRelatedParty	47975	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	464367	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	627548	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1038034	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1477665	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	1033877	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	995099	usd
	us-gaap	Operating Expenses OperatingExpenses	2086549	usd
	us-gaap	Operating Expenses OperatingExpenses	2116455	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1033877	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-995099	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2086549	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2116455	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	63313	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	140305	usd
	us-gaap	Interest Expense InterestExpense	111725	usd
	us-gaap	Interest Expense InterestExpense	396688	usd
CY2022Q2	CLCS	Interest Expense Related Parties InterestExpenseRelatedParties	130049	usd
CY2021Q2	CLCS	Interest Expense Related Parties InterestExpenseRelatedParties	22540	usd
	CLCS	Interest Expense Related Parties InterestExpenseRelatedParties	248402	usd
	CLCS	Interest Expense Related Parties InterestExpenseRelatedParties	47044	usd
CY2022Q2	CLCS	Amortization Of Debt Discount AmortizationOfDebtDiscount	23151	usd
CY2021Q2	CLCS	Amortization Of Debt Discount AmortizationOfDebtDiscount	155169	usd
	CLCS	Amortization Of Debt Discount AmortizationOfDebtDiscount	89688	usd
	CLCS	Amortization Of Debt Discount AmortizationOfDebtDiscount	277932	usd
CY2022Q2	CLCS	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	35204	usd
	CLCS	Amortization Of Debt Discount Related Party AmortizationOfDebtDiscountRelatedParty	41805	usd
	CLCS	Gain On Forgiveness Of Accrued Interest GainOnForgivenessOfAccruedInterest	49983	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-49718	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-251717	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-318014	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-491620	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-721399	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1285594	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1313113	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2578169	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2837854	usd
CY2022Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	244971	usd
CY2021Q2	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	225873	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	569888	usd
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	449264	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1530565	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1538986	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3148057	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3287118	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34438057	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32663482	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34419213	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32610275	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9826135	usd
CY2022Q1	CLCS	Conversion Of Convertible Notes Payable And Accrued Interest Into Series C Convertible Preferred Stock And Common Stock ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertiblePreferredStockAndCommonStock	1433095	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-324917	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8043	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	5372	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1292575	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-9997117	usd
CY2022Q2	CLCS	Conversion Of Convertible Notes Payable And Accrued Interest Into Series C Convertible Preferred Stock And Common Stock ConversionOfConvertibleNotesPayableAndAccruedInterestIntoSeriesCConvertiblePreferredStockAndCommonStock	114473	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-244971	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	597431	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	49219	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1285594	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-10766559	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-7947382	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-223391	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	196966	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	139728	usd
CY2021Q1	CLCS	Warrants Issued In Satisfaction Of Accrued Interest WarrantsIssuedInSatisfactionOfAccruedInterest	82350	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	206400	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	31276	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-1524741	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-9038794	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-9038794	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-225873	usd
CY2021Q2	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	474475	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	37512	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2540	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	36343	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-1313113	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-10026910	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-10026910	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2578169	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2837854	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	131493	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	277932	usd
	CLCS	Gain On Forgiveness Of Accrued Interest GainOnForgivenessOfAccruedInterest	49983	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-49718	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	63267	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	218985	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	206400	usd
	CLCS	Warrants Based Compensation WarrantsBasedCompensation	5034	usd
	CLCS	Warrants Based Compensation WarrantsBasedCompensation	67707	usd
	CLCS	Common Stock Based Compensation CommonStockBasedCompensation	9637	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-177839	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	37695	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-790	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-21584	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	158968	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	146895	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	403916	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-463996	usd
	CLCS	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-110000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-44729	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	223638	usd
	CLCS	Increasedecreasein Accrued Interest Related Parties IncreasedecreaseinAccruedInterestRelatedParties	320361	usd
	CLCS	Increasedecreasein Accrued Interest Related Parties IncreasedecreaseinAccruedInterestRelatedParties	1488	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	32476	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	17968	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1328754	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2257576	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	245000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2422250	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1000000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	168094	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	146912	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	199588	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	125000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	27926	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1238256	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2097662	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-90498	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-159914	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	93095	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	245119	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2597	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	85205	usd
CY2022Q2	us-gaap	Cash Cash	2597	usd
CY2021Q2	us-gaap	Cash Cash	81705	usd
CY2021Q2	us-gaap	Restricted Cash RestrictedCash	3500	usd
	CLCS	Accrual Of Earned Preferred Stock Dividends AccrualOfEarnedPreferredStockDividends	-569888	usd
	CLCS	Accrual Of Earned Preferred Stock Dividends AccrualOfEarnedPreferredStockDividends	-449264	usd
	CLCS	Common Stock Issued In Connection With Payment Of Series Convertible Preferred Stock Dividends Inkind CommonStockIssuedInConnectionWithPaymentOfSeriesConvertiblePreferredStockDividendsInkind	597431	usd
	CLCS	Common Stock Issued In Connection With Payment Of Series Convertible Preferred Stock Dividends Inkind CommonStockIssuedInConnectionWithPaymentOfSeriesConvertiblePreferredStockDividendsInkind	474475	usd
	CLCS	Issuance Of Common Stock Pursuant To Cashless Warrant Exercise IssuanceOfCommonStockPursuantToCashlessWarrantExercise	125	usd
	CLCS	Accrued Interest Converted Into Notes Payable AccruedInterestConvertedIntoNotesPayable	41950	usd
	CLCS	Issuance Of Warrants In Connection With Issuance Of Notes Payable IssuanceOfWarrantsInConnectionWithIssuanceOfNotesPayable	57262	usd
	CLCS	Issuance Of Warrants In Connection With Issuance Of Notes Payable IssuanceOfWarrantsInConnectionWithIssuanceOfNotesPayable	234478	usd
	CLCS	Accrual Of Warrant Obligations In Connection With Issuance Of Notes Payable AccrualOfWarrantObligationsInConnectionWithIssuanceOfNotesPayable	114727	usd
	CLCS	Issuance Of Warrants In Satisfaction Of Accrued Interest IssuanceOfWarrantsInSatisfactionOfAccruedInterest	82350	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1547568	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2578000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1329000	usd
CY2022Q2	CLCS	Working Capital Surplus Deficiency WorkingCapitalSurplusDeficiency	10767000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33757000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38540367	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31310383	shares
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.75
CY2021Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.75
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zuCACRdGWa56" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reclassifications</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period balances have been reclassified in order to conform to current year presentation. These reclassifications have no effect on previously reported results of operations or loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4	CLCS	Fair Value Inputs Measured On Recurring Basis Beginning Balance FairValueInputsMeasuredOnRecurringBasisBeginningBalance	463650	usd
CY2022Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	33197	usd
CY2022Q1	CLCS	Accrued Interest Warrant One AccruedInterestWarrantOne	114727	usd
CY2021Q2	CLCS	Accrued Interest Common Stock Obligation AccruedInterestCommonStockObligation	7097	usd
CY2022Q1	CLCS	Fair Value Inputs Measured On Recurring Basis Beginning Balance FairValueInputsMeasuredOnRecurringBasisBeginningBalance	611574	usd
CY2022Q2	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	29732	usd
CY2022Q2	CLCS	Fair Value Inputs Measured On Recurring Basis Beginning Balance FairValueInputsMeasuredOnRecurringBasisBeginningBalance	641306	usd
CY2020Q4	CLCS	Fair Value Inputs Measured On Recurring Basis Beginning Balance FairValueInputsMeasuredOnRecurringBasisBeginningBalance	624789	usd
CY2021Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	41704	usd
CY2021Q1	CLCS	Issuance Of Warrants IssuanceOfWarrants	-82350	usd
CY2021Q1	CLCS	Fair Value Inputs Measured On Recurring Basis Beginning Balance FairValueInputsMeasuredOnRecurringBasisBeginningBalance	584143	usd
CY2021Q2	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	37985	usd
CY2021Q2	CLCS	Accrued Interest Warrant One AccruedInterestWarrantOne	164857	usd
CY2021Q2	CLCS	Accrued Interest Common Stock Obligation AccruedInterestCommonStockObligation	7097	usd
CY2021Q2	CLCS	Fair Value Inputs Measured On Recurring Basis Beginning Balance FairValueInputsMeasuredOnRecurringBasisBeginningBalance	794082	usd
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	154495	shares
CY2021	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	154495	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	52528	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	52528	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	42930	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	82494	shares
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	74	usd
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	45972	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	5034	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	283744	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2019Q4	us-gaap	Litigation Settlement Amount Awarded From Other Party LitigationSettlementAmountAwardedFromOtherParty	267680	usd
CY2021	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	103088	usd
CY2022Q2	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	146912	usd

Files In Submission

Name	View Source	Status
0001493152-22-034255-index-headers.html	Edgar Link	pending
0001493152-22-034255-index.html	Edgar Link	pending
0001493152-22-034255.txt	Edgar Link	pending
0001493152-22-034255-xbrl.zip	Edgar Link	pending
clcs-20220630.xsd	Edgar Link	pending
ex31.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
clcs-20220630_def.xml	Edgar Link	unprocessable
clcs-20220630_cal.xml	Edgar Link	unprocessable
clcs-20220630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
clcs-20220630_lab.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLCS
Cell Source, Inc. Stock $clcs

2022 Q2 Form 10-Q Financial Statement

#000149315222034255 Filed on December 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLCS Cell Source, Inc. Stock $clcs

2022 Q2 Form 10-Q Financial Statement

#000149315222034255 Filed on December 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLCS
Cell Source, Inc. Stock $clcs